Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-04-18

Clinical Trial Update: St. John's Wort for Tobacco Cessation [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated St. John's Wort for tobacco cessation conducted by Mayo Clinic; the study is completed and results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • St. John's Wort (Hypericum perforatum)

Snippet

Sponsor: Mayo Clinic | Conditions: Smoking, Nicotine Dependence | Phase 2 | Status: COMPLETED | Results posted: 2011-04-18